Brief: Samsung Pharmaceutical To Invest 15.3 Billion Won To Build New Manufacturing Line
17/04/2019 08:40
April 17 (Reuters) - Samsung Pharmaceutical Co Ltd
001360.KS :
* SAYS TO INVEST 15.3 BILLION WON ($13.49 million) TO BUILD
NEW
MANUFACTURING LINE
Source text for Eikon: https://bit.ly/2PchLLE
Further company coverage: 001360.KS
($1 = 1,134.1500 won)
((Reuters Messaging:
hayoung.choi.thomsonreuters.com@reuters.net))
Recent news on Samsung Pharm
See all newsBrief: Samsung Pharmaceutical Wins 33.5 Billion Won Order
Brief: Samsung Pharmaceutical Says Acquires Shares Worth 12.5 bln Won In True Life Insurance Bank
Brief: Samsung Pharmaceutical To Invest 15.3 Billion Won To Build New Manufacturing Line
Brief: Samsung Pharmaceutical To Sell 8 Bln Won Asset To Samsung Medicos
Brief: Samsung Pharmaceutical Plans 20 Bln Won Investment In S.Korea